The investment case rests on a single structural fact: Embraer holds more signed, non-refundable aircraft orders than it can physically build for the next several years. Demand is not the issue, and the 2026 operating plan is a supply chain conversion exercise, not a sales effort.
The firm order backlog hit a record high in the second quarter, and the backlog level is $34.5 billion. The move is up 16% year over year, the steepest step in the order book since the regional jet recovery began. Revenue in that same quarter printed an all-time high of $2,235 million. The defense franchise is compounding faster than any other segment, with backlog up 42% and a book-to-bill of 2.6x. What that book-to-bill implies is that for every dollar of defense revenue recognized, nearly three new orders are being signed, which is the compounding signature the other three segments do not yet show.
The complication is margin, not demand. The commercial aviation segment earned a 2.9% adjusted EBIT margin in the second quarter, dragged by legacy contracts with limited pricing power. The consolidated 13.3% margin was flattered by a one-time tax credit. Excluding that item, the true run rate sits closer to 10.6%. That gap is the entire margin story: the consolidated print overstates the structural earning power of the business by a full quarter point or more, and the stock price has to decide which of the two numbers is the right anchor. The stock, at roughly $10.5 billion of market capitalization, is paying for the backlog but not yet for the margin expansion that the backlog implies.
The counterargument is the defense and services complex. The KC-390 just entered its first Middle East market. The OGMA engine line in Portugal is ramping toward a $650 million revenue run rate by 2030, which would make engine maintenance a material second revenue engine rather than a footnote. The 0.2x net debt to adjusted EBITDA ratio gives management real optionality to fund that ramp without external financing. The data from the next two quarters holds the answer. That single variable decides whether the stock sits at $8 billion or $20 billion, and the difference between those two outcomes is almost entirely a function of how fast the defense book-to-bill converts into recognized revenue.